fda warning letter glp-1 solution september 2025 sends after Chinese supplier breaks import restrictions FDA Decisions Expected: October 2025

The data were recorded with dates of events

Overall, this case suggests a role for prolonged fasting in combination with a GLP-1 as a bridge to bariatric surgery in carefully selected, highly-motivated patients

On Wednesday 4/1/26, the Food and Drug Administration (FDA) approved Eli Lillys new oral weight-loss pill, orforglipron , a GLP-1 drug that works like the widely used injectable medications

The 'DAC' (Drug Affinity Complex) modification, often associated with CJC-1295, extends its half-life, allowing for less frequent dosing

Veterans Affairs patients with diabetes

Single-cell map of diverse immune phenotypes in the breast tumor microenvironment